Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

747
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
747
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.1K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.1K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

355
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
355
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

349
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
349
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

550
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
550
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in vascular disorders of intestine mortality in the United States (1999-2024): disparities by sex, race/ethnicity, region, and urbanization.

Proceedings (Baylor University. Medical Center)·2026
Same author

Real-world evidence of the impact of aspirin use on esophageal cancer incidence in Barrett's esophagus patients.

Proceedings (Baylor University. Medical Center)·2026
Same author

Unsuspected efficacy of starch-based polysaccharide <i>vs</i> crystalloid-oil emulsion for lifting in colonic endoscopic resections.

World journal of gastrointestinal endoscopy·2025
Same author

Cardiac Arrest Mortality Across Time and Space: A National Analysis with Forecasts to 2035.

Journal of clinical medicine·2025
Same author

A 13-Year Nationwide Analysis of Nocardia and Actinomyces Infection Outcomes in Liver Transplant Recipients.

Transplantation proceedings·2025
Same author

Addressing the Gap: Racial Disparities and Public Health Strategies in the Epidemiology of Gastrointestinal Stromal Tumors.

Cureus·2024

Related Experiment Video

Updated: Dec 18, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.5K

Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions.

Jiten Desai1, Mohamed Elnaggar2, Ahmed A Hanfy2

  • 1Department of Internal Medicine, Nassau University of Medical Center, East Meadow, NY, USA.

Clinical and Experimental Gastroenterology
|June 18, 2020
PubMed
Summary

Toxic megacolon (TM), a severe complication of inflammatory bowel disease (IBD) or infections, involves colon dilation and toxicity. Prompt diagnosis and surgical intervention are crucial due to high mortality risks.

Keywords:
Clostridium difficile colitisinflammatory bowel diseasemanagement challenges and solutions for toxic megacolonnitric oxide synthasetoxic megacolon

More Related Videos

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.4K
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.8K

Related Experiment Videos

Last Updated: Dec 18, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.5K
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.4K
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.8K

Area of Science:

  • Gastroenterology
  • Colorectal Surgery

Background:

  • Toxic megacolon (TM) is a life-threatening complication of inflammatory bowel disease (IBD) and infectious colitis.
  • It presents with nonobstructive colonic dilation and systemic toxicity, leading to significant morbidity and mortality.

Purpose of the Study:

  • To review the complex management challenges of toxic megacolon.
  • To explore potential management strategies for toxic megacolon.

Main Methods:

  • Review of clinical presentation, diagnostic methods, and treatment options for toxic megacolon.
  • Emphasis on the importance of accurate history, physical examination, and imaging.

Main Results:

  • Diagnosis is facilitated by clinical awareness, history, physical exam, abdominal radiographs, and sigmoidoscopy.
  • Surgical intervention is often necessary for cases with hemorrhage, perforation, peritonitis, or refractory medical therapy.

Conclusions:

  • Toxic megacolon requires prompt recognition and management due to its severe prognosis.
  • A multidisciplinary approach involving medical and surgical teams is essential for optimal patient outcomes.